IκBζ regulates the development of nonalcoholic fatty liver disease through the attenuation of hepatic steatosis in mice
Authors:
Open Access
- 8 July 2022
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 12 (1) , 1-14
Abstract
IκBζ is a transcriptional regulator that augments inflammatory responses from the Toll-like receptor or interleukin signaling. These innate immune responses contribute to the progression of nonalcoholic fatty liver disease (NAFLD); however, the role of IκBζ in the pathogenesis of NAFLD remains elusive. We investigated whether IκBζ was involved in the progression of NAFLD in mice. We generated hepatocyte-specific IκBζ-deficient mice (Alb-Cre; Nfkbizfl/fl) by crossing Nfkbizfl/fl mice with Alb-Cre transgenic mice. NAFLD was induced by feeding the mice a choline-deficient, L-amino acid-defined, high-fat diet (CDAHFD). CDAHFD-induced IκBζ expression in the liver was observed in Nfkbizfl/fl mice, but not in Alb-Cre; Nfkbizfl/fl mice. Contrary to our initial expectation, IκBζ deletion in hepatocytes accelerated the progression of NAFLD after CDAHFD treatment. Although the increased expression of inflammatory cytokines and apoptosis-related proteins by CDAHFD remained unchanged between Nfkbizfl/fl and Alb-Cre; Nfkbizfl/fl mice, early-stage steatosis of the liver was significantly augmented in Alb-Cre; Nfkbizfl/fl mice. Overexpression of IκBζ in hepatocytes via the adeno-associated virus vector attenuated liver steatosis caused by the CDAHFD in wild-type C57BL/6 mice. This preventive effect of IκBζ overexpression on steatosis was not observed without transcriptional activity. Microarray analysis revealed a correlation between IκBζ expression and the changes of factors related to triglyceride biosynthesis and lipoprotein uptake. Our data suggest that hepatic IκBζ attenuates the progression of NAFLD possibly through the regulation of the factors related to triglyceride metabolism.Keywords
Funding Information
- Bristol Myers Squibb
- Otsuka Pharmaceutical
This publication has 46 references indexed in Scilit:
- An improved mouse model that rapidly develops fibrosis in non‐alcoholic steatohepatitisInternational Journal of Experimental Pathology, 2013
- NASH is an Infl ammatory Disorder: Pathogenic, Prognostic and Therapeutic ImplicationsGut and Liver, 2012
- Hepatic activation of IKK/NFκB signaling induces liver fibrosis via macrophage-mediated chronic inflammationHepatology, 2012
- Human Fatty Liver Disease: Old Questions and New InsightsScience, 2011
- NF-κB in the liver—linking injury, fibrosis and hepatocellular carcinomaNature Reviews Gastroenterology & Hepatology, 2011
- Lipin — The bridge between hepatic glycerolipid biosynthesis and lipoprotein metabolismBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2010
- Biochemistry, physiology, and genetics of GPAT, AGPAT, and lipin enzymes in triglyceride synthesisAmerican Journal of Physiology-Endocrinology and Metabolism, 2009
- Design and validation of a histological scoring system for nonalcoholic fatty liver disease†Hepatology, 2005
- Regulation of Toll/IL-1-receptor-mediated gene expression by the inducible nuclear protein IκBζNature, 2004
- MAIL, a novel nuclear IκB protein that potentiates LPS‐induced IL‐6 productionFEBS Letters, 2000